The race to produce a coronavirus vaccine accelerated on Monday when the German group BioNTech announced a $135m partnership with Fosun Pharma of China to develop a Covid-19 vaccine, which it said could begin clinical testing in late April.
研制新型冠狀病毒疫苗的競賽周一提速。德國生物技術(shù)集團BioNTech宣布與中國復(fù)星醫(yī)藥(Fosun Pharma)達成一項涉資1.35億美元的合作，以開發(fā)COVID-19疫苗。該公司表示，這種疫苗有望于4月下旬開始臨床試驗。
您已閱讀8%（352字），剩余92%（3968字）包含更多重要信息，訂閱以繼續(xù)探索完整內(nèi)容，并享受更多專屬服務(wù)。